{
    "document_number": "2025-03775",
    "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2025-03-07/pdf/2025-03775.pdf",
    "publication_date": "2025-03-07",
    "title": "Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China",
    "summary": "The document is an Executive Order (14228) issued by the President on March 3, 2025, which amends previous measures addressing the synthetic opioid supply chain from the People's Republic of China (PRC). The order highlights the ongoing threat posed by the influx of synthetic opioids, particularly fentanyl, from the PRC to the United States, which has been deemed a significant risk to national security, foreign policy, and the economy.\n\nKey findings include:\n- The PRC has not taken sufficient actions to mitigate the illicit drug crisis, leading to the amendment of tariffs on products from the PRC from 10% to 20%.\n- The order reinforces the authority to impose these tariffs under the International Emergency Economic Powers Act and other relevant laws.\n\nImplications of this order suggest an escalation in economic pressure on the PRC to address the opioid crisis and a commitment from the U.S. government to enhance its enforcement measures against the flow of synthetic opioids. The order clarifies that it does not create legal rights enforceable against the U.S. government or its entities.",
    "doc_type": "executive_order"
}